Recent successes in therapeutics for Ebola virus disease: no time for complacency

PL Iversen, CD Kane, X Zeng, RG Panchal… - The Lancet Infectious …, 2020 - thelancet.com
The PALM trial in the Democratic Republic of the Congo identified a statistically significant
survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute …
被引用次数：53 相关文章

Recent successes in therapeutics for Ebola virus disease: no time for complacency.

PL Iversen, CD Kane, X Zeng, RG Panchal… - The Lancet. Infectious …, 2020 - europepmc.org
The PALM trial in the Democratic Republic of the Congo identified a statistically significant
survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute …
[HTML] nih.gov

[HTML][HTML] Recent successes in therapeutics for Ebola virus disease: no time for complacency

PL Iversen, CD Kane, X Zeng, RG Panchal… - The Lancet. Infectious …, 2020 - ncbi.nlm.nih.gov
The PALM trial in the Democratic Republic of the Congo identified a statistically significant
survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute …

Recent successes in therapeutics for Ebola virus disease: no time for complacency

PL Iversen, CD Kane, X Zeng… - The Lancet …, 2020 - pubmed.ncbi.nlm.nih.gov
The PALM trial in the Democratic Republic of the Congo identified a statistically significant
survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute …

Recent successes in therapeutics for ebola virus disease: no time for complacency.

PL Iversen, CD Kane, X Zeng, RG Panchal, TK Warren… - 2020 - cabidigitallibrary.org
The PALM trial in the Democratic Republic of the Congo identified a statistically significant
survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute …

Recent successes in therapeutics for Ebola virus disease: no time for complacency

PL Iversen, CD Kane, X Zeng, RG Panchal… - The Lancet Infectious …, 2020 - Elsevier
The PALM trial in the Democratic Republic of the Congo identified a statistically significant
survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute …

Recent successes in therapeutics for Ebola virus disease: no time for complacency.

PL Iversen, CD Kane, X Zeng, RG Panchal… - The Lancet. Infectious …, 2020 - europepmc.org
The PALM trial in the Democratic Republic of the Congo identified a statistically significant
survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute …